Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice by Sato, Toshiya et al.
Severe neurological phenotypes of Q129
DRPLA transgenic mice serendipitously created
by en masse expansion of CAG repeats in Q76
DRPLA mice
Toshiya Sato1, Masami Miura5, Mitsunori Yamada2, Takayuki Yoshida6,{, Jonathan D. Wood7,{,
Ikuru Yazawa10, Masao Masuda5, Takeo Suzuki5,11, Ryong-Moon Shin5,}, Hau-Jie Yau12, Fu-Chin
Liu12, Takayoshi Shimohata3, Osamu Onodera4, Christopher A. Ross7,8,9, Motoya Katsuki13,
Hitoshi Takahashi2, Masanobu Kano6,§, Toshihiko Aosaki5 and Shoji Tsuji14, 
1Department of Comparative and Experimental Medicine,
2Department of Pathology,
3Department of Neurology and
4Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata 951-8585, Japan,
5Neural Circuits Dynamics Research Group, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-
0015, Japan,
6Department of Cellular Neurophysiology, Graduate School of Medical Science, Kanazawa University,
Kanazawa, Ishikawa 920-8640, Japan,
7Department of Psychiatry,
8Department of Neurology and
9Department of
Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA,
10Laboratory of
Research Resources, National Institute for Longevity Sciences, Obu, Aichi 474-8522, Japan,
11Department of
Anesthesiology, School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan,
12Institute of
Neuroscience, National Yang-Ming University, Li-Rum Street, Taiwan 11221, Taiwan,
13National Institute for Basic
Biology, Okazaki National Research Institutes, Okazaki, Aichi 444-8585, Japan and
14Department of Neurology,
Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan
Received August 1, 2008; Revised and Accepted November 25, 2008
We herein provide a thorough description of new transgenic mouse models for dentatorubral–pallidoluysian
atrophy (DRPLA) harboring a single copy of the full-length human mutant DRPLA gene with 76 and 129 CAG
repeats. The Q129 mouse line was unexpectedly obtained by en masse expansion based on the somatic
instability of 76 CAG repeats in vivo. The mRNA expression levels of both Q76 and Q129 transgenes were
each 80% of that of the endogenous mouse gene, whereas only the Q129 mice exhibited devastating pro-
gressive neurological phenotypes similar to those of juvenile-onset DRPLA patients. Electrophysiological
studies of the Q129 mice demonstrated age-dependent and region-speciﬁc presynaptic dysfunction in the
globus pallidus and cerebellum. Progressive shrinkage of distal dendrites of Purkinje cells and decreased
currents through a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and g-aminobutyrate type A recep-
tors in CA1 neurons were also observed. Neuropathological studies of the Q129 mice revealed progressive
brain atrophy, but no obvious neuronal loss, associated with massive neuronal intranuclear accumulation
(NIA) of mutant proteins with expanded polyglutamine stretches starting on postnatal day 4, whereas NIA
in the Q76 mice appeared later with regional speciﬁcity to the vulnerable regions of DRPLA. Expression pro-
ﬁle analyses demonstrated age-dependent down-regulation of genes, including those relevant to synaptic
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Advance Access published on November 27, 2008functions and CREB-dependent genes. These results suggest that neuronal dysfunction without neuronal
death is the essential pathophysiologic process and that the age-dependent NIA is associated with nuclear
dysfunction including transcriptional dysregulations. Thus, our Q129 mice should be highly valuable for
investigating the mechanisms of disease pathogenesis and therapeutic interventions.
INTRODUCTION
Dentatorubral–pallidoluysian atrophy (DRPLA; MIM 125370)
is a devastating, autosomal-dominant neurodegenerative
disease characterized by progressive dementia, cerebellar
ataxia, choreoathetosis, myoclonus and epilepsy in various
combinations depending on the age at onset (1). As indicated
by the name, autopsied brains show a selective neuronal loss
associated with astrocytosis in the dentatorubral and pallidoluy-
sian (DRPL) systems (2). In 1994, we and another group, focus-
ing on genes containing CAG repeats (3), found that DRPLA is
caused by an unstable expansion of CAG repeats coding for
polyglutamine (polyQ) stretches in exon 5 of the DRPLA
geneonchromosome12p13.31(4,5).Todate,polyQexpansions
have been identiﬁed as the pathogenic mutations in nine neuro-
degenerative diseases including Huntington’s disease (HD),
spinal and bulbar muscular atrophy, DRPLA and various
forms of dominant spinocerebellar ataxias (SCAs) (6).
The discovery of neuronal intranuclear inclusions (NIIs) not
only in brains of transgenic mice (7) but also in autopsied brains
with polyQ diseases (8,9) provided new insight into neuronal
nuclei as a potentially important site of pathogenic mechanisms.
More importantly, we demonstrated that a diffuse accumulation
of a mutant DRPLA protein (atrophin-1) in the neuronal nuclei
of autopsied brains, rather than the formation of NIIs, is the pre-
dominant pathologic condition involving a wide range of
central nervous system (CNS) regions far beyond the vulnerable
DRPL systems (10). To further emphasize the involvement of
nuclear dysfunction in polyQ diseases, we have demonstrated
that expanded polyQ stretches bind to TATA-binding protein
(TBP)-associated factors (TAFII130) and cAMP response
element-binding protein (CREB)-binding protein (CBP), which
are components of transcriptional regulators (11,12). Taken
together, these ﬁndings strongly suggest that essential pathoge-
netic processes occur in neuronal nuclei. The molecular mechan-
isms of neurodegeneration, however, remain to be elucidated.
To investigate these molecular mechanisms, studies on
animal models precisely replicating all the processes in the
human brain would be indispensable. For high-quality
animal models, the expression of a full-length mutant gene
under the control of its own promoter is preferable to those
expressing truncated mutant proteins or under the control of
potent heterologous promoters. To meet these requirements,
we have generated transgenic mice harboring a single copy
of the full-length human mutant DRPLA gene containing 76
CAG repeats (13). These Q76 mice did not exhibit obvious
neurological phenotypes. During intensive breeding of Q76
mice, however, we unexpectedly found a mosaic mouse har-
boring largely expanded CAG repeats (Q129), in addition to
the 76 repeats from progenitor mice, which bred transgenic
offspring carrying 129 CAG repeats exhibiting distinct
behavioral abnormalities. The Q129 mice showed severe
neurological phenotypes with progressive brain atrophy and
premature death. Some neuropathological ﬁndings of the
Q129 mice at 14 weeks of age focusing on morphometric
analysis have recently been reported, which demonstrate
atrophy of the perikarya and dendrites, and a decrease in the
number and size of the spines without any obvious neuronal
loss (14). We herein report a thorough characterization of
the phenotypes of Q129 mice, including electrophysiological
abnormalities, neuropathological ﬁndings focusing on age-
dependent neuronal intranuclear accumulation (NIA) of
mutant DRPLA proteins and nuclear dysfunction assessed by
expression proﬁling. As shown here, Q129 mice harboring a
single copy of the full-length DRPLA gene have many advan-
tages over the previous Q76 mice, and should serve as excel-
lent models for exploring the molecular mechanisms of CAG
repeat instability, disease pathogenesis and, furthermore,
therapeutic intervention for polyQ diseases.
RESULTS
En masse expansion of CAG repeats occurred via somatic
instability in a Q76 mouse
We previously established three transgenic lines, which were
generated by the transfer of a cosmid genomic clone contain-
ing the full-length human mutant DRPLA gene with 78 CAG
repeats (13). Although the mice showed intergenerational
instabilities of CAG repeats similar to those observed in
DRPLA patients, no obvious abnormal phenotypes were
detected. To investigate intergenerational instabilities, we con-
tinued our extensive breeding of the Drm21 line carrying the
76 CAG repeats (Q76 mice). During the process, we unexpect-
edly noticed one male mouse (EF121) carrying both 76 and
129 CAG repeats among over 2000 hemizygous mice
[Fig. 1A, Mosaic (Q129-76)]. After the birth of the EF121
mouse, the male parent of the EF121 mouse bred only Q76
or non-transgenic (non-TG) mice (n ¼ 66 and 54, respect-
ively). On the other hand, the highly expanded 129 CAG
repeats, of which sequence was uninterrupted (unpublished
data), were transmitted from the EF121 mouse to certain off-
spring exhibiting behavioral abnormalities (Q129 mice). These
results suggest that the EF121 mouse is a mosaic with respect
to the length of CAG repeats of the transgene and that the 129
CAG repeats were presumably generated by the en masse
expansion of the 76 CAG repeats at the early embryonic stage.
Although the EF121 mosaic mouse was smaller than the
Q76 mice and exhibited a slightly ataxic phenotype with
age, the mouse was able to continue to breed and sired 528
mice by 122 weeks of age. The percentages of transgenic off-
spring of Q129, Q76 and non-TG mice bred from the EF121
mosaic mouse were 19% (n ¼ 98), 32% (n ¼ 170) and 49%
(n ¼ 260), respectively. Because one-half of the offspring
were non-TG mice, the EF121 mosaic mouse was considered
to be a hemizygote. Furthermore, the segregation ratios of 19
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repeats had occurred either at the two-cell or four-cell stage.
The Q129 mice were established by in vitro fertilization
because of their decreased fertility. The fertilizing ability of
spermatozoa from the Q129 mice was comparable to that of
the wild-type mice, suggesting that the reduced fertility is
due to behavioral abnormalities.
Phenotypes of Q129 mice are similar to those of
juvenile-onset DRPLA patients
The onset of symptoms was as early as 3 weeks of age, at which
the Q129 mice began to show myoclonic movements and mild
ataxia (Fig. 1C). When held by the tail, the myoclonic move-
ments were more evident with limbs outstretched. The clasping
of hindlimbs was hardly observed. The myoclonic movements
and ataxia rapidly progressed, and epilepsy was observed at
around 11 weeks. Initially, epilepsy was induced by tactile
stimuli and at the later stage, it occurred spontaneously, even
in their home cages. The rapid progression of the disease phe-
notype was followed by premature death, and all the Q129
mice died by 16 weeks (Fig. 1B and C; Supplementary
Material, Videos S1 and S2, ataxia and epilepsy, respectively).
The severe neurological phenotypes observed in the Q129
mice, namely myoclonus and epilepsy, were quite similar to
those observed in juvenile-onset DRPLA patients with onset
before the age of 20 (1,15). These phenotypes are in striking
contrast to those of the Q76 mice that do not show any
obvious neurological phenotypes.
The brain weight was less than that of the Q76 or non-TG
mice at 4 weeks of age, even at a time when body weight
did not change. Along with the disease progression, the
brain weight of the Q129 mice further decreased after 6
weeks of age prior to the decrease in body weight (Fig. 1D;
Supplementary Material, Tables S1 and S2). The examination
of brain cross-sections further demonstrated the age-dependent
decrease in the brain size of the Q129 mice at 4, 6 and 14
weeks of age (Fig. 1E). In addition, the Q129 mice became
polyuric around 5 weeks of age, a phenomenon that was not
observed in the Q76 mice. Detailed analyses of water
balance were conducted at 8 weeks of age. The Q129 mice
showed increased urine volume, water intake and serum
osmolality, and reduced urine osmolality (Fig. 1F). Further-
more, we found a drastic reduction in the plasma vasopressin
(anti-diuretic hormone) level, conﬁrming that the Q129 mice
suffered from central diabetes insipidus.
Dysfunction of pallidal and cerebellar neurons correlates
with disease manifestations and progression
We ﬁrst conducted electrophysiological studies of the globus
pallidus (GP) and cerebellum, because these structures are
highly associated with neuropathological changes in DRPLA.
Using the Q129 and non-TG mice at 4–5 weeks of age, we per-
formed whole-cell recordings from pallidal neurons. Excitatory
(EPSCs) and inhibitory postsynaptic currents (IPSCs) were
evokedbyactivatingthesub-thalamopallidalandstriatopallidal
pathways,respectively.Wedidnotdetectanysigniﬁcantdiffer-
ences in input–output (I–O) relationships (Fig. 2Aa).
In addition, current–voltage (I–V) relationships and the
Figure 1. Generation of Q129 transgenic mice and disease phenotypes.
(A) PCR analysis of tail DNA revealed two hemizygous mosaic mice
(Q129-76 and Q76-65), a hemizygous mouse (Q76) and the offspring of the
Q129-76 mosaic mouse showing three genotypes (Q129, Q76 and non-TG).
The lane for the Q129-76 mosaic mouse showed a faint extra band of a much
larger size than the band corresponding to 76 CAG repeats. The large
changes in the size of CAG repeats resulted in not only expansion (Q129-76),
but also contraction (Q76-65). (B) Kaplan–Meier survival curves of Q76 (tri-
angles) and Q129 (circles) mice, showing premature death of Q129 mice
(n ¼ 20). (C) Representative photographs of the Q129 mice at 12 weeks (W),
showing ataxic phenotype (left panel), ubiquitinated NIIs (middle panel) and
epileptic seizure (right panel). (D) Changes in body and brain weights of the
Q129 (circles), Q76 (triangles) and non-TG (rectangles) mice. Each value
and number of replicates is shown in Supplementary Material, Tables S1 and
S2. (E) Cross-sections of brains of the Q129 mice (4W, 6W and 14W) and
non-TG littermate (14W) (Klu ¨ver–Barrera staining), showing progressive
reduction in brain size of Q129 mice. (F) Results of laboratory tests indicate
central diabetes insipidus. Each value indicates mean+S.E.M. Unpaired
t-test,  P , 0.05,   P , 0.01. Numbers of replicates are shown in parentheses.
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a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
components of EPSCs were not signiﬁcantly different (unpub-
lished data). In contrast, the paired pulse facilitation (PPF) of
EPSCs and IPSCs was clearly converted to paired pulse
depression (PPD) in the Q129 mice (Fig. 2Ab and Ac),
suggesting presynaptic dysfunction in GP of the Q129 mice
at 4–5 weeks of age.
For electrophysiological studies of the cerebellum, we con-
ducted whole-cell recordings from medium to large neurons in
the fastigial nucleus (FN) obtained from young asymptomatic
mice aged 8–13 days. IPSCs evoked by stimulating putative Pur-
kinje cell (PC) axons displayed PPD in both non-TG and Q129
mice (Fig. 2B). There was no signiﬁcant difference in the
extent of PPD. Thus, on postnatal days 8–13 before the manifes-
tation of ataxia, transmission from PCs to neurons in FN (one of
the deep cerebellar nuclei) in the Q129 mice was apparently
normal. Further studies of neurons in the GP and FN at later
stages could not be performed because of the limited time
window suitable for such electrophysiological analyses.
To investigate age-dependent changes in the cerebellum, we
next compared the electrophysiological properties of PCs at 4
and 12 weeks of age. The passive membrane properties of PCs
were calculated by recording membrane currents in response
to hyperpolarizing voltage steps, as described previously
(16). We found that the C2 of the Q129 mice, representing
the lumped membrane capacitance of the PC’s dendritic tree,
was signiﬁcantly smaller than that of the non-TG mice at 12
weeks of age (P , 0.01), whereas no signiﬁcant changes
were observed at 4 weeks of age (Table 1). In addition, R3
of the Q129 mice, representing the lumped resistance of the
PC’s dendritic tree, tended to be greater than that of the
non-TG mice at 12 weeks of age. These results suggest that
the PC’s dendritic trees of the Q129 mice markedly shrank
in a time-dependent manner.
We then examined whether excitatory synaptic transmission
to PCs is altered in the Q129 mice. We recorded EPSCs from
PCs by stimulating climbing ﬁbers (CFs: axons of inferior
olivary neurons) or parallel ﬁbers (PFs: axons of granule
cells). We ﬁrst conﬁrmed that the number of CFs innervating
a PC was not signiﬁcantly different between the non-TG and
Q129 mice at 4 or 12 weeks of age (unpublished data). As
for the kinetics of CF-EPSCs, the rise time or amplitude was
not signiﬁcantly altered in the Q129 mice except for a slight
decrease in the decay time constant in the Q129 mice at 4
and 12 weeks of age (Table 1). At 4 weeks of age, there
was no signiﬁcant difference in the extent of PPD of
CF-EPSC or PPF of PF-EPSC (Fig. 2Ca and Da). At 12
weeks of age, however, paired pulse ratios (PPRs) for
CF-EPSC and PF-EPSC in the Q129 mice were signiﬁcantly
smaller than those in the non-TG mice at interpulse intervals
of 50–1500 ms and those at intervals of shorter than 50 ms,
respectively (Fig. 2Cb and Db).
Dysfunction of synaptic transmission in hippocampal
CA1 pyramidal cells
Although the hippocampus is not a severely affected region
in DRPLA, NIA of mutant DRPLA proteins was observed
in juvenile-onset DRPLA patients (10), and also conﬁrmed in
Figure 2. Age-dependent abnormalities of synaptic transmission in GP and
cerebellum. Pallidal and cerebellar slices were obtained from the Q129 mice
(ﬁlled circles) and non-TG mice (open circles) at various ages as indicated
in each ﬁgure. (Aa–Ac) Whole-cell recordings from pallidal neurons of the
Q129 and non-TG mice at 4–5 weeks of age. I–O relationship for EPSC
(Aa), PPRs for EPSC (Ab) and IPSC (Ac) in GP. EPSCs and IPSCs were
evoked by stimulating the sub-thalamopallidal and striatopallidal pathways,
respectively, at 0.1 Hz with a bipolar tungsten electrode (100–500 ms,
100–800 mA). IPSCs were recorded at a holding potential of 210 mV in
the presence of CNQX and D-AP5. EPSCs of the Q129 mice (n ¼ 14)
tended to be smaller than those of the non-TG mice (n ¼ 21), which
showed no statistically signiﬁcant difference (Aa). PPRs for EPSC (Ab) and
IPSC (Ac) in the Q129 mice (n ¼ 12 and 11, respectively) decreased as com-
pared with those of the non-TG mice (n ¼ 22 and 15, respectively), resulting
in the conversion of PPF to PPD in the Q129 mice at 4–5 weeks of age. (B)
PPR for IPSC in FN on postnatal days 8–13. IPSCs were evoked by stimulat-
ing bundles of putative PC axons. There was no signiﬁcant difference between
the Q129 mice (n ¼ 12) and the non-TG mice (n ¼ 30). (Ca–Db) Age-
dependent changes in PPRs for CF-EPSCs and PF-EPSCs. CF-EPSCs were
recorded from PCs at 4 (Ca) and 12 weeks (Cb) of age in the Q129 (n ¼
19 and 27, respectively) and non-TG mice (n ¼ 20 and 30, respectively).
PF-EPSCs were recorded from PCs at 4 (Da) and 12 weeks (Db) of age in
the Q129 (n ¼ 14 and 27, respectively) and non-TG mice (n ¼ 22 and 28,
respectively). For focal stimulation in the cerebellar slices, we used a
bipolar tungsten electrode (for PC axons) and glass pipettes (5–10-mm tip
diameter) ﬁlled with standard saline (for CFs and PFs), and applied square
pulses (duration, 100 ms; amplitude, 0–90 V) at 0.5 Hz. Bundles of putative
PC axons were stimulated in the white matter 100–200 mm away from the
FN. CFs were stimulated in the granule cell layer 50–100 mm away from
the PC soma. PFs were stimulated in the middle of the molecular layer.
Each value indicates mean+S.E.M. Unpaired t-test,  P , 0.05,   P , 0.01.
Note that the abscissas of B–Db are shown in the logarithmic scale.
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campus may well be involved in the pathological processes of
DRPLA. To evaluate the electrophysiological properties of hip-
pocampal CA1 pyramidal cells, we ﬁrst analyzed basal synaptic
transmission by applying electrical stimuli of increasing inten-
sity to the Schaffer collateral/commissural pathway using
Q129 and non-TG mice at 12–15 weeks of age. The extracellu-
lar recordings showed that the ﬁeld excitatory postsynaptic
potential (fEPSP) slopes of the Q129 mice were signiﬁcantly
smaller than those of the non-TG mice at 12–15 weeks of age
(Fig. 3A). A signiﬁcantly enhanced PPF was also observed in
the Q129 mice (Fig. 3B at 100 ms, P ¼ 0.024; at 150 ms, P ¼
0.002), suggesting presynaptic dysfunction.
In the whole-cell recordings from CA1 neurons, the ratio of
NMDA/AMPA currents in the Q129 mice was signiﬁcantly
larger than that in the non-TG mice, despite the observation
that I–V relationships of AMPA, NMDA and g-aminobutyrate
type A (GABAA) currents were unchanged (unpublished
data). To further investigate the mechanisms underlying the
increased ratio of NMDA/AMPA currents, we compared
responses to the agonists of AMPA, NMDA and GABAA
receptors. AMPA-induced inward currents were signiﬁcantly
smaller in the Q129 mice than in the non-TG mice across
the ﬁve concentrations tested (Fig. 3Ea), whereas there were
no signiﬁcant changes in NMDA-induced inward currents
(Fig. 3Eb). Similar to AMPA currents, GABAA-induced
outward currents were signiﬁcantly smaller in the Q129
mice than in the non-TG mice at elevated muscimol concen-
trations (Fig. 3Ec).
We next analyzed the long-term potentiation (LTP) of
fEPSPs in the hippocampal CA1 region. LTP induced by
one train of tetanic stimulation lasted for more than 4 h in
the non-TG mice, whereas it subsided within 2 h in the
Q129 mice (Fig. 3C). The average fEPSP slope within a
time window of 120–180 min after tetanus in the Q129
mice was 98.7+9.3%, which was signiﬁcantly lower than
that in the non-TG mice (132.8+4.5%, P ¼ 0.004). In con-
trast, four trains of tetanic stimulation induced late-phase
LTP in both genotypes to the same extent (Fig. 3D).
Age- and expanded-polyQ-length-dependent NIA of
mutant DRPLA proteins
In accordance with our previous ﬁndings in the Q129 mice at 14
weeksofage(14),anage-dependentdecreaseinthebrainsizeof
the Q129 mice was evident (Fig. 1E), but neuronal loss or astro-
cytosis was not evident despite the progressive brain atrophy
(Fig. 4). In hematoxylin- and eosin-stained preparations, small
eosinophilic intranuclear inclusions were detectable in some
neurons of restricted CNS regions of the Q129 mice after 12
weeks of age (unpublished data). In immunohistochemical
analysis using anti-ubiquitin antibodies, they were easily
detected after 9 weeks of age as ubiquitinated NIIs in multiple
CNS regions such as the cerebral cortex, GP, subthalamic
nucleus (luysian body), brainstem tegmentum and deep cerebel-
lar nuclei (Fig. 1C). It should be noted, however, that NIIs were
formed much later than the onset of neurological phenotypes,
suggesting that the disease phenotypes do not arise from the for-
mation of NIIs. In contrast to the Q129 mice, we did not detect
any evidenceofNIIsinthe brain ofQ76 miceevenat 122 weeks
of age (unpublished data).
To ﬁnd age-dependent changes focusing on the regional dis-
tribution of NIA, we performed immunohistochemical ana-
lyses of the Q76 and Q129 mice at various weeks of age
using highly diluted 1C2 (1:16 000). At this dilution, no back-
ground immunoreactivities were detected in the brain of the
non-TG mice, conﬁrming that 1C2 immunoreactivity is
speciﬁc to the expanded polyQ stretches of mutant proteins
(Fig. 4A, right panels) (10). In contrast to the non-TG mice,
1C2 immunoreactivity was clearly evident as a diffuse
nuclear labeling of neurons in the 4-week-old brain of the
Q129 mice (Fig. 4A, middle panels). The nuclear labeling,
namely NIA, was strong and extended to most of the CNS
regions including the brainstem, spinal cord and the regions
evaluated for the above-mentioned electrophysiological prop-
erties. It should be noted that NIA, which was observed at 4
weeks of age in the Q129 mice, occurred much earlier than
the appearance of NIIs after approximately 9 weeks of age.
To determine when NIA becomes apparent, we further




a n ¼ 6 n ¼ 11
C1 (pF) 60.4+8.8 69.8+10.0
C2 (pF) 617.3+58.8 571.2+46.8
R1 (MV) 14.8+3.4 13.2+1.2
R2 (MV) 21.3+5.1 19.4+2.0
R3 (MV) 308.1+68.2 211.0+29.9
CF-EPSC n ¼ 15 n ¼ 18
10–90% rise time (ms) 0.4+0.01 0.4+0.01
Decay time constant (ms)
b 7.7+0.3   6.6+0.3  
Amplitude at 210 mV (pA) 1114.1+111.4 1126.2+139.9
Amplitude at þ50 mV (pA) 768.1+179.6 812.2+241.8
Postnatal 12 weeks
Passive membrane properties
a n ¼ 14 n ¼ 19
C1 (pF) 95.5+13.4 80.8+11.1
C2 (pF) 629.9+63.5   332.6+18.9  
R1 (MV) 11.1+0.6 11.4+1.1
R2 (MV) 15.8+3.8 16.7+1.7
R3 (MV) 241.2+47.4 405.3+76.5
CF-EPSC n¼23 n ¼ 26
10–90% rise time (ms) 0.4+0.03 0.4+0.01
Decay time constant (ms)
b 6.9+0.3   5.9+0.3  
Amplitude at 210 mV (pA) 1150.9+98.8 1312.0+140.4
Amplitude at þ50 mV (pA) 1085.2+182.9 1771.3+297.7
a Parameters for passive membrane properties are calculated according to
the model described by Llano et al. (16), which distinguishes two regions
of PCs: region 1, representing the soma and the main proximal dendrites,
and region 2, representing the dendritic tree. C1 and C2 represent the
lumped membrane capacitance of regions 1 and 2, respectively. R1
represents the pipette access resistance. Region 2 is linked to region 1 by
resistor R2, representing the lumped resistance between the main proximal
dendrite and each membrane region of distal dendrites. R3 represents the
lumped resistance of the dendritic tree of PCs. C1, C2, R1 and R2 are
calculated from the initial capacitive currents in response to
hyperpolarizing voltage steps (500-ms duration) from 270 to 280 mV.
R3 is measured from the steady-state currents in response to
hyperpolarizing voltage steps (500-ms duration) from 280 to 285 mV.
bDecaytime constantsfor CF-EPSCaremeasuredbyﬁttingEPSCdecaywitha
single exponential. The holding potential was 280 mV.
All data are expressed as mean+S.E.M.
  P , 0.01 (t-test).
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NIA was not observed in the brain of Q129 mice on postnatal
day 1 (P1), but became detectable on P4, conﬁrming age-
dependent NIA of mutant DRPLA proteins (Fig. 4B).
Interestingly, NIA was also observed in the Q76 mouse
brain despite the Q76 mice not showing any obvious neuro-
logical phenotypes. In contrast to the Q129 mice, the intensity
of NIA was weak in the brains of Q76 mice, but increased with
age (Fig. 4A, left panels). The regional distribution of NIA in
the Q76 mice was analyzed semiquantitatively (Table 2). NIA
was ﬁrst detectable at 4 weeks of age in limited CNS regions,
such as the cerebellar nuclei, red nucleus, GP, subthalamic
nucleus and a few other regions including the cerebral
cortex of the Q76 mice. It is noteworthy that the former four
regions are the sites known to be the most vulnerable to
DRPLA (1,2). Furthermore, the distribution of NIA in the
brains of Q76 mice at 14 weeks of age became similar to
that of NIIs in the brains of Q129 mice.
Since 1C2 immunoreactivity varies depending on the length
of polyQ stretches, immunohistochemical analyses with 1C2
may produce some bias in terms of accumulation of mutant
DRPLA proteins with different lengths of expanded polyQ
stretches. We further conducted immunohistochemical analyses
using APG840 raised against residues 425–439 of the DRPLA
protein (10) that correspond to the upstream region of the
polyQ stretches. In contrast to 1C2, APG840 recognized not
only human mutant DRPLA proteins, but also endogenous
mouse wild-type DRPLA proteins (Fig. 4C). Although back-
ground nuclear staining was observed in the non-TG mice as
APG840 recognized mouse DRPLA protein, strong nuclear
staining was observed in the Q129 mice at as early as 4 weeks
of age. In the Q76 mice, mild but increased staining was
observedat14weekscomparedwiththatat4weeks.Theseﬁnd-
ingsfurtherconﬁrmpolyQ-length-dependentandage-dependent
intranuclear accumulation of mutant DRPLA proteins.
Massive accumulation of mutant DRPLA proteins
in Q129 mouse brain
First, we performed quantitative analyses of the mRNA
expression levels of the human DRPLA transgene and
endogenous mouse DRPLA gene in the brains of the Q76
and Q129 mice at 8 weeks of age by competitive reverse tran-
scription–polymerase chain reaction (RT–PCR) (Fig. 5A).
After conﬁrming the validity of the quantitative analysis by
PCR, the mRNA expression levels of the transgenes of the
Q129 and Q76 mice were determined to be 80% of the
mouse endogenous level.
Western blot analysis was performed using three antibodies:
C580 (17; a polyclonal antibody against the carboxyl terminus
of the DRPLA protein), AP142 (18; a polyclonal antibody
against residues 425–439) and 1C2 (speciﬁcally recognizes
expanded polyQ stretches). In the total homogenates of the
mouse brain, two bands corresponding to the full-length
mouse endogenous DRPLA protein (200 kDa) and transgene-
derived DRPLA proteins (210 and 220 kDa in Q76 and Q129,
respectively) were detected using C580, whereas only the
lower band corresponding to the full-length mouse DRPLA
protein was observed for the non-TG mice (Fig. 5B). In
addition to the 200-kDa band, a 100-kDa band was detected
in human autopsied control brain, consistent with previous
observations on human DRPLA brains employing C580
(17). The intensities of the bands of the full-length DRPLA
proteins of Q129 were much weaker than those corresponding
Table 2. Distribution of NIA of expanded polyQ stretches in Q76 mice
Region Gestational age Region Gestational age
4W 8W 14W 4W 8W 14W
Cerebral cortex Thalamic nuclei
II 2 þþ þCentrolateral 22 þþ
III 2 þþ þ þ Ventroposterior 22 þ
IV þ þþþ þþþ Reticular 22 þþ
V 2 þþSubthalamic nucleus þþ þ þ þ þ
VI 2 þþ þþþ Hypothalamic nuclei 2 þþ þ
Piriform cortex 2 þþ þ Substantia nigra
Caudate-putamen 2 þþ þPars compacta 2 þþ þþþ
Globus pallidus þþ þ þ þ þ Pars reticulata 2 þþ þ
Hippocampus Superior colliculus 2 þþ þ þ
CA1 22 þ Periaqueductal gray 2 þþ þ
CA2 22 þ Deep mesencephalic nucleus 2 þþ þ þ
CA3 22 þ Red nucleus þþ þ þ þ þ
Dentate gyrus Pontine nuclei 2 þþ þ þ
Granule cell layer 22 þ Pontine reticular nucleus þþ þ þ þ þ
Polymorphic cell layer 22 þ Vestibular nucleus 2 þþ þþþ
Amygdaloid nuclei þþ þ þ Facial nucleus 22 2
Lateral habenular nucleus 2 þþ þ þ Inferior olive 22 2
Medial habenular nucleus 22 2 Gigantocellular reticular ﬁeld þþ þ þ þ þ
Thalamic nuclei Purkinje cell 22 2
Mediodorsal 22 þ Granule cell 2 þþ þ
Centromedial 22 þþ Cerebellar nuclei þþ þ þ þ þ
At 4 weeks of age, nuclear labeling was detected not only in the DRPL systems, but also in some brain regions including the cerebral cortex and
brainstem nuclei. Thereafter, the number and intensity of labeled neurons increased gradually throughout the brain with a speciﬁc distribution pattern.
Percentage of labeled neurons: 2, none; þ, ,30%; þþ, 30–70%; þþþ, .70%.
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which may reﬂect the highly aggregatable nature of mutant
DRPLA proteins with highly expanded polyQ stretches that
may be resistant to extraction or solubilization procedures.
Although the reason why the intensities of full-length mutant
proteins decreased in the Q129 mice was unclear, a similar
observation was described for SCA1
154Q/2Q mice (19). The
intensities of the bands detected by C580 were similar
throughout the time course of 4, 8 and 12 weeks of age.
To further analyze the proteins accumulating in the nucleus,
we prepared nuclear fractions employing the sucrose gradient
centrifugation procedure as previously described (20) from
the brains of Q129, Q76 and non-TG littermates at 12 weeks
of age, and performed western blot analysis using AP142 that
recognizes the segment upstream of polyQ stretches. A
massive amount of smear migrating between the stacking gel
and the band corresponding to the full-length mutant protein
was observed for the Q129 mice, in addition to human full-
length and truncated bands as well as the mouse endogenous
band (Fig. 5C). The truncated proteins were also recognized
by 1C2 (unpublished data) and thus speciﬁc for mutant
DRPLA proteins as described previously (20). The smear was
far more intense for the Q129 mice than for the Q76 mice, con-
ﬁrming the polyQ-length-dependent nuclear accumulation of
the mutant proteins with expanded polyQ stretches. The smear-
ing pattern was also observed in AT-FL-65Q-150 mice
(Fig. 5C; lane 1) as previously described. AT-FL-65Q-150
mice are transgenic mice carrying full-length DRPLA cDNA
under the control of the prion promoter and expressing higher
levels of the transgene than the Q129 mice (20). Although the
intensities of the truncated bands and the smears were consider-
ably different between Q129 and AT-FL-65Q-150, this may
reﬂect the higher expression levels of mutant DRPLA proteins
in AT-FL-65Q-150 and regional differences in expression
depending on the promoter driving the transgenes (Q129:
own promoter of DRPLA gene; ATFL-65Q: prion promoter).
The difference in the western blotting patterns detected by
AP142 and C580 raises many possibilities, including that a
fraction of accumulated mutant DRPLA proteins in the
nucleus are truncated at the carboxy terminus. This possibility
should be thoroughly investigated employing sensitive
procedures including additional antibodies.
Transcriptional down-regulation becomes prominent
in an age-dependent manner
As described above, the most fundamental pathological
change was the age- and expanded-polyQ-length-dependent
NIA of mutant proteins without any obvious neuronal loss,
raising the possibility that such an NIA of mutant proteins
leads to neuronal dysfunction including synaptic transmissions
through transcriptional dysregulations. Thus, we analyzed
expression proﬁles (11 000 genes) in the brains of the
Q129 and non-TG littermates at 4 and 12 weeks of age using
GeneChip Mu11K oligonucleotide microarrays (Affymetrix,
Santa Clara, CA). To determine how gene expressions are
affected as a function of disease duration, we selected dysre-
gulated genes at each age using one-way analysis of variance
(ANOVA) with error-weighting. On the basis of our criteria
described in Materials and Methods, we detected 54 and 92
Figure 3. Abnormalities of synaptic transmission and plasticity in hippo-
campus. Hippocampal slices were obtained from the Q129 mice (ﬁlled
circles) and the non-TG mice (open circles) at 12–15 weeks of age.
(A) The I–O relationship showed a signiﬁcant attenuation of the responsive-
ness of CA1 pyramidal cells in the Q129 mice (n ¼ 12) as compared with that
in the non-TG mice (n ¼ 13). The slopes of fEPSPs evoked by stimulating the
Schaffer collateral/commissural pathway are plotted against stimulus intensity.
Inset: examples of fEPSPs of the Q129 (upper) mouse and the non-TG (lower)
mouse. Scale bars: 2 mV/10 ms. (B) The PPR for the fEPSP slope of CA1 hip-
pocampal cells in the Q129 mice (n ¼ 12) was enhanced as compared with
that in the non-TG mice (n ¼ 13) at 13–15 weeks of age. (C) LTP induced
by one train of tetanus (a small arrow) subsided within 120 min in the Q129
mice (n ¼ 10), whereas LTP in the non-TG mice (n ¼ 10) lasted much
longer. (D) Late-phase LTP induced by four trains of tetanus (a large
arrow) was not signiﬁcantly different between the Q129 mice (n ¼ 5) and
the non-TG mice (n ¼ 5). Data in C and D are normalized for each slice
with respect to the average slope recorded during the baseline. (Ea–Ec)
Pharmacological evidence for functional down-regulation of AMPA and
GABAA receptors in hippocampus of Q129 mice at 12–15 weeks of age.
AMPA-induced inward current (Ea) was recorded at a holding potential of
260 mV in the presence of 0.1 mM cyclothiazide, which prevents the rapid
desensitization of AMPA receptors and 0.5 mM TTX. NMDA-induced
inward current (Eb) was recorded at a holding potential of 240 mV in the pre-
sence of 20 mM glycine and 0.5 mM TTX in Mg
2þ-free ACSF.
Muscimol-induced outward current (Ec) was recorded at a holding potential
of 0 mV. Drug exposure time was 1 min throughout the experiments. The
ﬂow rate was 2–3 ml/min. Each value indicates mean+S.E.M. Unpaired
t-test,  P , 0.05,   P , 0.01.
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sets at 4 and 12 weeks of age, respectively. The number of
down-regulated genes tended to increase with age. We next
searched for genes showing age-dependent changes in the
levels of expression determined by the two-way ANOVA.
We found 46 down-regulated genes (corresponding to 48
probe sets on the microarrays) and 26 up-regulated genes.
Interestingly, many of the down-regulated genes were categor-
ized mainly into speciﬁc functional molecules, such as neuro-
peptides, transcriptional factors and signaling molecules
(Fig. 6). Although all of the down-regulated genes showed
further decreases in expression level with age, the degrees of
decrease were different and a limited number of the genes,
mainly categorized into neuropeptides, showed a marked
decrease (fold change ,21.5) at 4 weeks of age. To
determine the relevance of the down-regulated genes to
CREB-dependent transcriptional dysregulation, we examined
whether these down-regulated genes are candidates for
CREB target genes (21,22). We found that 21 of the 46
(46%) down-regulated genes and 17 of the 28 (61%) strongly
down-regulated genes (fold change ,21.5; shown in blue in
Fig. 6) have cAMP response element (CRE) sites that are
conserved between human and rodent orthologs. Among the
down-regulated genes, we further conﬁrmed decreased
protein levels of arginine vasopressin (Fig. 1F) and kalirin
(see Supplementary Material, Fig. S1).
DISCUSSION
Q129 mice as a model to understand the mechanisms
of en masse expansion or contraction of CAG repeats
We established the Q129 DRPLA transgenic mice by utilizing
a unique phenomenon, en masse expansion of CAG repeats.
Figure 4. Age- and expanded-polyQ-length-dependent changes in NIA of mutant DRPLA proteins. (A) Immunohistochemical analysis of cerebral cortices of the
Q76, Q129 and non-TG mice was performed using 1C2. The upper panels show the entire cerebral cortices and the lower panels show cortical layer III. In the
Q129 mice (middle panels), the decrease in cortical size was already evident at 4 weeks of age and the cerebral cortex progressively atrophied with age. Neuronal
nuclei in all the cortical layers showed intense labeling of expanded polyQ stretches and became gradually packed with age. Age-dependent nuclear atrophy and
deformity were also observed (lower panels). There was no obvious neuronal loss in the Q129 mouse brain. In the Q76 mice (left panels), there was no obvious
decrease in cortical size. In the lower panels, a gradual increase in the number of neuronal nuclei labeled by 1C2 was observed. Such nuclear labeling became
evident particularly in the cortical layers IV and VI. Scale bar ¼ 100 mm for upper panels and 20 mm for lower panels. (B) Immunohistochemical analysis of
cerebral cortical layer VI and GP of the Q129 mice using 1C2 revealed faint NIA on P4, but not on P1. Scale bar¼20 mm. (C) Immunohistochemical analysis of
cerebral cortical layer III using APG840, an anti-DRPLA protein (atrophin-1) antibody, also revealed polyQ-length-dependent and age-dependent intranuclear
accumulation of mutant DRPLA proteins. Scale bar ¼ 20 mm.
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expansion. We previously showed age-dependent changes in
expanded CAG repeats in somatic tissues as well as interge-
nerational instabilities of expanded CAG repeats (13). The
mechanism of instability has been assumed to be cumulative
accumulation of short repeat changes with age, typically
one-repeat additions or subtractions. In contrast, en masse
expansion (Fig. 1A, lane 1) or contraction (Fig. 1A, lane 2)
is quite different in terms of the frequency and length of
repeat changes. The large intergenerational increase in the
CAG repeats to expanded alleles from the intermediate
alleles has been observed in a small number of HD or SCA7
patients, and is called the de novo expansion (23–25). This
phenomenon may be similar to the en masse expansion
observed in this study. Based on these observations, there
seem to be two discrete mechanisms of CAG repeat instability:
cumulative accumulation of short repeat changes with age and
en masse changes occurring spontaneously, but infrequently.
Because the mosaic mice were hemizygous, inter-allelic
recombination mechanisms are unlikely to be involved. We
previously reported a patient with en masse expansion of
impure CAG repeats in the TBP gene. In this case, inter-allelic
recombination events were excluded on the basis of haplotype
analysis (26). These intriguing observations suggest that
simple intra-allelic rearrangements are involved in the CAG
repeat instabilities associated with en masse expansions or
contractions, which have also been suggested to be involved
in somatic instability of minisatellites (27). Taking advantage
of the instability of the 129 CAG repeats, we have recently
obtained transgenic models carrying 113 or 96 CAG repeats
with moderately severe neurological phenotypes (unpublished
observation). Thus, transgenic models carrying single copy
genes within a full-length genomic context may serve to
produce those with variable lengths of expanded CAG repeats.
Q129 mice as an excellent model to understand disease
pathogenesis of DRPLA
The Q129 and Q76 mice should be highly valuable for inves-
tigating expanded-polyQ-length-dependent effects, because
the only difference between the Q129 and Q76 mice is the
length of expanded CAG repeats within an identical inte-
gration site. The severe neurological phenotypes of the Q129
mice are quite similar to those observed in juvenile-onset
DRPLA patients. It should be noted, however, that the pheno-
types of Q129 mice were distinct from previously generated
mouse models of polyQ diseases. The Q129 mice showed
myoclonus, epilepsy and progressive brain atrophy, which
are the predominant clinical presentations in DRPLA patients.
In contrast, feet clasping observed in R6/2 mice, SCA1
knock-in mice and DRPLA cDNA mice of AT-FL-65Q-150
(19,20,28) was absent in the Q129 mice. Electrophysiological
abnormalities have been shown to vary considerably among
polyQ models, even among HD yeast artiﬁcial chromosome
transgenic, HD knock-in and R6/2 mice (29–31), suggesting
that the synaptic dysfunctions underlying the distinct pheno-
types are dependent on the promoters, copy numbers and the
contexts of transgenes. Thus, the Q129 mice harboring a
single copy of the full-length human DRPLA gene under the
control of its own promoter should be highly valuable for
investigating the molecular pathogenesis of DRPLA.
NIA of mutant DRPLA proteins is the essential
pathophysiologic process
The regional distribution of NIA, particularly that of Q76 mice,
is prominent in DRPL systems, the most vulnerable regions in
DRPLA patients (1). We have also observed a similar regional
distribution of NIA in human autopsied brains (10). In contrast
to the Q76 mice, a massive NIA of mutant DRPLA proteins
Figure 5. Quantiﬁcation of mutant DRPLA mRNA levels and western blot
analysis of DRPLA proteins in Q129 mouse brains. (A) The expression
levels of DRPLA mRNAs derived from the transgene and mouse endogenous
DRPLA gene were quantiﬁed by competitive RT–PCR. Considering that the
length of the homo-serine stretch in the human DRPLA gene is 9 bp longer
than that in the mouse DRPLA gene, we ampliﬁed a segment of DRPLA
genomic DNA or cDNAs using ﬂanking primers that completely match both
the human and mouse genomic sequences. The validity of the quantitative
analysis was conﬁrmed by gene dosage analysis of human mutant transgenes
when compared with endogenous mouse DRPLA genes. The expression levels
of human DRPLA gene-derived mRNAs of Q129 and Q76 were determined
for each to be 80% of the endogenous mouse DRPLA mRNA level.
(B) Western blot analysis of total brain homogenates employing C580
revealed two bands corresponding to mouse endogenous (arrowheads) and
transgene derived DRPLA proteins in the Q76 or Q129 mice. The lane for
human control brain carrying 13 and 9 CAG repeats (lane 1) showed a
weak band corresponding to the full-length human DRPLA protein. The inten-
sities of the full-length protein in autopsied brains have been shown to be vari-
able, possibly due to the intrinsic instability of the DRPLA protein, and the
identity of the 100-kDa band detected by C580 remains unknown as pre-
viously described (17). (C) Western blot analysis of nuclear fractions using
AP142 showed smears migrating between the stacking gel and the full-length
bands. The smaller bands, possibly truncated, with polyQ-length-dependent
mobility shifts were observed in Q129 and Q76. As a comparison, other
DRPLA transgenic mouse models (20; AT-FL-26Q-84 and AT-FL-65Q-150
at 7.5 months of age) were also analyzed. In the lane for AT-FL-65Q mice,
a massive amount of smears as well as truncated proteins with a faster mobility
than those in the lane for Q129 mice were observed.
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NIA was not present on P1 even in the Q129 mice, but was the
earliest change among any other abnormalities including neuro-
logical phenotypes and electrophysiological abnormalities. It
should also be mentioned that the distribution of NIA far
exceeded the DRPL systems. This may provide an explanation
as to the controversial issue that the neuronal loss involving
DRPLsystems alonecannotaccount for the broad clinical mani-
festationsofDRPLA.Inparticular,massiveNIAobservedinthe
cerebral cortex may account for the development of dementia,
myoclonus and epilepsy. Taken together, these observations
strongly suggest that NIA plays essential roles in the pathogen-
esis of DRPLA.
The mechanisms underlying the regional speciﬁcity of NIA
of mutant DRPLA proteins, however, remain to be elucidated.
Interestingly, NIA of mutant DRPLA proteins appeared after
P4 even in the Q129 mice, whereas the transcript is abundantly
expressed as early as embryonic day 5 and thereafter (32).
Figure 6. Expression proﬁles in brains of the Q129 mice compared with those in the non-TG littermates. The fold changes of the genes in the Q129 mice (n ¼ 3)
compared with those in the non-TG mice (n ¼ 3) and the intensities in the Q129 mice at 4 or 12 weeks of age are summarized, which were calculated with the
Rosetta Resolver (Ratio Experiment) using the Affymetrix-Default Ratio Builder. Fold changes are shown as columns of blue, light blue, yellow and pink indi-
cating fold changes of ,22.0, 21.5, 21.2 and others, respectively. Filled circles: CREB targets described by Mayr and Montminy (21). Filled triangles: puta-
tive CREB targets classiﬁed as conserved CRE (22). Genes of neuropeptides in the Q129 mice, including vasopressin, oxytocin, somatostatin and neuropeptide
Y, were strongly down-regulated even at 4 weeks of age. The latest description of each gene was obtained from the Probe Set at the NetAffx Analysis Center
(www.affymetrix.com).
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dependent NIA of mutant DRPLA proteins starting on P4.
Although further analysis is required, we speculate that
regional differences in the synthesis, processing and subcellu-
lar localizations of mutant DRPLA proteins (33–35) play key
roles in the region-speciﬁc distribution of NIA.
Neuronal dysfunction without neuronal loss is
essential in DRPLA pathogenesis
Intriguingly, we have not observed any neuronal loss in the
brains of the Q129 mice despite the progressive brain atrophy
and severe neurological phenotypes. Indeed, the electrophysio-
logical analyses demonstrated age-dependent and region-
speciﬁc synaptic dysfunction along with disease progression.
We demonstrated presynaptic dysfunction (altered PPRs) in
PCs and pallidal neurons, and postsynaptic dysfunction (shrink-
age of distal dendrites of PCs and decreased currents through
AMPA and GABAA receptors in CA1 neurons). These obser-
vations strongly argue for the concept of ‘neuronal dysfunction
without neuronal death’. Our recent morphometric studies
demonstrated marked reductions in the number and size of
spines, further supporting synaptic dysfunction (14).
The concept of neuronal dysfunction without neuronal death is
apparently contradictory to the neuropathological ﬁnding that
neuronal loss conﬁned to DRPL systems is the hallmark of
DRPLA. As discussed above, neurological phenotypes presum-
ably reﬂect neuronal dysfunction as a result of NIA, and neuronal
loss may well be the latest event observed in advanced stages.
Supporting this concept, juvenile-onset DRPLA patients initially
donotshowmarkedlyatrophicchangesinthecerebelluminmag-
netic resonance imaging, in contrast to markedly atrophic
changes observed in late-adult-onset DRPLA patients (36).
Transcriptional dysregulations and neuronal dysfunction
Inthisstudy,wehaveidentiﬁedgenesthataredown-regulatedin
an age-dependent manner, including those coding for neuropep-
tides,transcriptionalfactorsandsignalingmolecules.Becauseof
the functional relevance and strong down-regulation even at 4
weeks of age, kalirin is of particular interest, which is a multi-
functional Rho guanine nucleotide exchange factor, also
known as the huntingtin-associated protein interacting protein
(37). The age-dependent decrease in the expression level of
kalirin in the Q129 mouse brain was further conﬁrmed by
western blot analysis (Supplementary Material, Fig. S1). It has
been demonstrated that the down-regulation of kalirin results
inreducedlinearspinedensityandtheeliminationofpresynaptic
endings in CA1 hippocampal neurons (38). Because the
reductioninspinedensityisthemoststrikingchangeinourmor-
phometric analysis of Q129 mice (14), the down-regulation of
kalirin might be directly involved in synaptic dysfunction.
Although the functional relevance was not discussed, the down-
regulation of kalirin was also observed in R6/2 mice (39;
described as the expression sequence tag AA673405).
In the category of neuropeptides, arginine vasopressin
showed the most striking down-regulation, which is consistent
with the phenotype of central diabetes insipidus. Although
clinically apparent endocrinological dysfunction has not
been described in DRPLA patients, detailed investigations
should be carried out on DRPLA patients, particularly on
those with juvenile-onset DRPLA and highly expanded CAG
repeats. Given the behavioral abnormalities observed in mice
with their neuropeptides knocked out, including somatostatin
(MGI:98326, impairment in motor learning) and neuropeptide
Y (MGI:97374, seizure), the down-regulation of these neuro-
peptides may also contribute in part to the behavioral abnorm-
alities of the Q129 mice. Dbp (MGI:2183196), Fos
(MGI:95574) or excitatory amino acid transporter 2 (Slc1a2,
MGI:101931) knock-out mice show seizures, suggesting that
the down-regulation of these genes may also contribute to
the neurological phenotypes of Q129 mice.
As shown in Figure 6, 46% of down-regulated and 61% of
strongly down-regulated genes (fold change ,21.5) have
CRE sites. These observations support our previous ﬁnding
that CREB-dependent transcriptional activation is strongly sup-
pressed by expanded polyQ stretches in cellular models
(11,12,40). A role for CREB-mediated signaling in neurodegen-
eration has been provided by Mantamadiotis et al. (41),asdeter-
mined using conditional CREB knock-out mice. They described
that mice lacking both CREB and cAMP response element
modulator protein (CREM) in the postnatal forebrain showed
progressive neurodegeneration of the striatum and hippocampus
after 1.5 months, and a neurological phenotype after 6 months,
supporting the hypothesis that disruption of CREB-dependent
transcription plays an essential role in neurodegeneration in
polyQ diseases through transcriptional dysregulations.Although
we focused on CREB-dependent transcription, it has recently
been reported that expanded polyQ stretches disrupt the struc-
tures of TAFIID and TAFIIF of the basal transcriptional appar-
atus (42). Thus, the down-regulation of genes may involve
multiple mechanisms in addition to the down-regulation of
CREB target genes; further investigations on the mechanisms
underlying transcriptional dysregulations caused by expanded
polyQ stretches should be carried out.
We should emphasize the concept of neuronal dysfunction
without neuronal death as the essential pathophysiologic
mechanism underlying polyQ diseases, which are associated
with transcriptional dysregulations. This concept is further
supported by a previous study that demonstrated the reversible
recovery of phenotypic presentations in an HD mouse model
after the shut-off of the expression of truncated mutant hun-
tingtin (43). A recent report of deﬁcits in experience-
dependent cortical plasticity in presymptomatic HD mice
(44) further strengthens this concept. This concept strongly
emphasizes a wider time interval for therapeutic interventions.
Because our Q129 mice closely replicate pathophysiologic
processes in the human brain, as supported by the insertion
of a single copy gene with its own promoter, the Q129 mice
should be an ideal model for exploring possibilities for thera-
peutic interventions aimed at polyQ diseases.
MATERIALS AND METHODS
Generation and background of Q129 mice
Q76 transgenic mice were previously established in N1 proge-
nies (Drm21 line) with agouti coat color that were generated
from a CCE ES clone (13). Q76 mice were backcrossed to
C57BL/6J, and the EF121 mosaic mouse (Q129-76) that
Human Molecular Genetics, 2009, Vol. 18, No. 4 733bred the Q129 mice (see Results) was found in the N3 gener-
ation. The EF121 mosaic mouse was also crossed with
C57BL/6J females. Q129 mice used for analyses of pheno-
types and expression proﬁling were from the N4 or N5 gener-
ation, and those used for electrophysiological analysis were
from N6 or later generations. Q129 mice were established
by in vitro fertilization using male transgenic mice at 12
weeks of age.
Brain slice preparation
Q129 transgenic mice or their age-matched non-TG littermates
at either 1 to 2 weeks, 4–5 weeks or 12–15 weeks of age were
decapitated under ether anesthesia. Their brains were isolated
and were placed in ice-cold artiﬁcial cerebrospinal ﬂuid
(ACSF) containing NaCl (124 mM), KCl (3 mM), NaH2PO4
(1 mM), MgCl2 (1.2 mM), CaCl2 (2.4 mM) and glucose
(10 mM), buffered at pH 7.4 with NaHCO3 (26 mM) and satu-
rated with 95% O2 and 5% CO2. The cerebellar and pallidal
slices were cut parasagittally (250 mm thick) as previously
described (45,46). For the preparation of hippocampal slices
(250 and 400 mm thick; used for whole-cell and ﬁeld record-
ing, respectively), hippocampal formations were dissected
free and cut with a tissue slicer.
Field recording
Hippocampal fEPSPs were recorded using glass electrodes
(ﬁlled with ACSF) placed in the stratum radiatum of area
CA1. Field EPSPs were evoked by stimulating the Schaffer
collateral/commissural pathway with short current pulses
(50 ms duration; 0.033 Hz) using a Teﬂon-coated bipolar tung-
sten electrode (Microprobe, Potomac, MD). LTP was induced
by either one or four trains of tetanic stimulation (100 pulses/
100 Hz; intertrain interval, 2 s) and monitored for 4–5 h after
the tetanic stimulation to detect late-phase LTP.
Whole-cell recording
Whole-cell patch-clamp recording was made by infrared differ-
ential contrast visualization. For voltage-clamp recording in the
GP and hippocampus, patch pipettes (4–6 MV) containing
Cs-methanesulfonate (124 mM), KCl (11 mM), MgCl2 (2 mM),
HEPES (10 mM), Na2-ATP (4 mM), GTP (0.3 mM), spermine
(0.1 mM), QX-314 (5 mM) and 0.5% biocytin (adjusted to
280 mOsm and pH 7.3 with CsOH) were used. For recording
fromneuronsincerebellarnuclei,patchpipettes(4–6 MV)con-
taining CsCl (30 mM), CsOH (110 mM), EGTA (1.0 mM),
HEPES (10 mM), MgCl2 (4.6 mM), CaCl2 (0.1 mM), Na2-ATP
(4 mM) and Na2-GTP (0.4 mM) (pH 7.3, adjusted with
D-gluconate, 280 Osm, ECl ¼ 230 mV) were used. For record-
ing from PCs in the cerebellar cortex, patch pipettes (3–5 MV)
containing CsCl (60 mM), Cs D-gluconate (10 mM), TEA-Cl
(20 mM), BAPTA (20 mM), HEPES (30 mM), MgCl2 (4 mM),
Na2-ATP (4 mM)a n dN a 2-GTP (0.4 mM) (pH 7.3, adjusted
with CsOH, 280 Osm) were used.
Bicuculline methiodide (20 mM) was added to isolate
glutamatergiccurrents.ToisolateGABAAreceptor-mediatedcur-
rents, the NMDA receptor antagonist D(2)-2-amino-5-phospho-
nopentanoic acid (D-AP5, 25 mM) and the AMPA receptor
antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX,
10 mM )w e r ea p p l i e dt oA C S F .
Immunohistochemical analysis
Q129, Q76 and non-TG littermates were anesthetized in ether
and perfused with phosphate-buffered saline followed by 4%
paraformaldehyde. The brains were removed and immersed
in the same ﬁxative for 16 h. Parafﬁn-embedded, 4-mm-thick
sections were prepared and subjected to immunostaining
with a rabbit polyclonal antibody against ubiquitin at 1:3200
dilution (Dako, Tokyo, Japan), the mouse monoclonal anti-
body 1C2 at 1:16 000 dilution (Chemicon, Temecula, CA)
and goat polyclonal antibody APG840 at 1:2000 dilution as
described previously (10).
RT–PCR analysis
Total RNAs were extracted from the brains (whole cerebrum
and cerebellum). To avoid contamination with genomic
DNA, total RNAs were extracted twice using ISOGEN
(Nippon Gene, Tokyo, Japan) and converted into cDNA by
priming with random hexamers using an Advantage
RT-for-PCR Kit (Clontech, Mountain View, CA). PCR was
performed in a 50 ml mixture containing 2.5 U AmpliTaq
DNA polymerase (Applied Biosystems, Foster City, CA),
10 mM Tris–HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2,
200 mM dNTP and 5 pmol of each primer with an antisense
primer labeled with FAM (50-CTGCCCTGAGACCCCTCAA
C-30,5 0-FAM-TGGGATGGGAGAGAAGGCTG-30). After
an initial denaturation at 968C for 2 min, PCR was performed
for 30 cycles consisting of denaturation at 968C for 45 s,
annealing at 608C for 1 min and extension at 728Cf o r
1 min, followed by a ﬁnal extension at 728C for 10 min.
PCR products were quantiﬁed by determining the area of the
chromatogram using an ABI 310 DNA sequencer and Genes-
can version 2.1 software (Applied Biosystems).
Western blot analysis
Brain samples from age-matched Q129, Q76 and non-TG lit-
termates at 4, 8 and 12 weeks of age were prepared. From
AT-FL-26Q-84 and AT-FL-65Q-150 mice (20), samples
were obtained at 7.5 months of age; these mice were trans-
genic, expressing full-length DRPLA cDNAs encoding 26
and 65 CAG repeats, respectively. Sample preparation and
western blot analysis were performed as described previously
(17,20). Total homogenates, 20 mg per lane, and nuclear
extracts, 30 and 35 mg per lane, were subjected to western
blot analysis using the rabbit polyclonal antibody C580 (17),
polyclonal antibody AP142 (18) and 1C2 (Chemicon),
respectively.
Expression proﬁling analysis
Total RNAs were extracted similar to those for the RT–PCR
analysis. Brain polyA(þ) RNAs were prepared using an
Oligotex-dT30kSuperlmRNA Puriﬁcation Kit (Takara, Otsu,
Japan) and subjected to hybridization using Mu11KsubA
and B oligonucleotide arrays (GeneChip) according to the
734 Human Molecular Genetics, 2009, Vol. 18, No. 4manufacturer’s instructions (Affymetrix). Statistical analyses
were performed by error-weighted ANOVA using the Rosetta
Resolver gene expression data analysis system (Rosetta Bio-
software, Seattle, WA). For determining the number of dysre-
gulated genes at 4 or 12 weeks of age, one-way ANOVA was
ﬁrst applied using intensity data (Time Slice). For post hoc
analysis, the dysregulated genes, each of which showed both
a signiﬁcant difference in ratio data and an absolute fold
change  1.5, were selected using the Rosetta Resolver (Ratio
Experiment). For identifying the genes showing age-dependent
changes, two-way ANOVA (variables: animal and time) was
ﬁrst applied. For post hoc analysis, genes showing a signiﬁcant
difference in ratio data at 12 weeks of age were selected using
the Ratio Experiment. A P-value of ,0.05 was considered to
indicate a statistically signiﬁcant difference.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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